Why Is Dual-Wavelength Q-Switched Nd:yag Laser Therapy Effective For Treating Hori's Macules (Abnom)? Explore The Science And Clinical Applications.

Dual-wavelength Q-switched Nd:YAG therapy is effective for Hori’s macules because it matches two laser wavelengths to the condition’s variable pigment depth. The 532 nm wavelength primarily targets more superficial melanin, while the 1064 nm wavelength penetrates farther into the dermis, where the melanocytes responsible for ABNOM are mainly located. Their short, high-energy pulses selectively fragment melanin while limiting heat exposure to surrounding skin, helping explain why combined treatment can outperform single-wavelength therapy.

Core takeaway: Hori’s macules contain pigment at different depths, so a single wavelength may treat only part of the problem. Combining 532 nm and 1064 nm Q-switched Nd:YAG treatment provides broader depth coverage and can improve clearance, although outcomes depend on appropriate settings, skin type, and treatment technique.

Why Hori’s Macules Require Depth-Targeted Treatment

The pigment is located within the dermis

ABNOM consists of acquired dermal melanocytes dispersed through the papillary and mid-dermis. This makes it different from purely epidermal pigmentation, which can often be treated with more superficial approaches.

Because the pigment is distributed across more than one dermal level, treatment must deliver sufficient energy to both relatively superficial and deeper pigment deposits.

Pigment depth varies between lesions

Not every macule has the same depth, density, or distribution of melanin. Some areas may respond to a more superficial wavelength, while others require deeper penetration.

This variation is a major reason that dual-wavelength treatment can be more comprehensive than relying on one wavelength alone.

How the Two Wavelengths Work Together

The 532 nm wavelength addresses superficial pigment

The 532 nm wavelength is strongly absorbed by melanin and is useful for targeting pigment closer to the skin surface. In ABNOM treatment, it may help address superficial components of the pigmentation, although the condition itself is primarily dermal rather than epidermal.

Its relatively superficial action can complement, rather than replace, treatment of deeper melanocytes.

The 1064 nm wavelength reaches deeper melanocytes

The 1064 nm wavelength penetrates more deeply into tissue and is better suited to the dermal component of ABNOM. It also experiences less absorption by epidermal melanin than shorter wavelengths, which can be advantageous when treating deeper pigment, particularly in patients with more melanin in the epidermis.

This deeper reach is central to treating the melanocytes that produce Hori’s macules.

Combined treatment improves depth coverage

Using both wavelengths allows clinicians to address pigment across a broader tissue depth. The 532 nm wavelength contributes superficial targeting, while the 1064 nm wavelength treats deeper deposits.

This complementary action helps explain the higher complete-clearance rates and improved clinical outcomes reported with combined treatment compared with single-wavelength monotherapy.

Why Q-Switched Pulses Are Appropriate

Short pulses target pigment selectively

Q-switched lasers deliver very brief, high-power pulses. These pulses can concentrate energy in melanin-containing structures and fragment the pigment through a predominantly photoacoustic and photothermal effect.

The goal is to disrupt pigment-containing cells or melanin particles without creating unnecessary thermal injury in surrounding tissue.

Surrounding skin receives less collateral heating

Because the pulse duration is extremely short, there is less time for heat to spread into adjacent skin than with longer-pulsed treatment. This selective action supports treatment efficiency and can reduce—but does not eliminate—the risk of unwanted tissue injury.

Patient discomfort is often manageable, but pain and recovery vary according to fluence, spot size, treatment density, skin type, and individual sensitivity.

What Determines Clinical Effectiveness

Appropriate energy settings are essential

Wavelength alone does not determine the result. Fluence, spot size, pulse characteristics, repetition rate, and treatment intervals must be selected according to lesion depth, skin type, and the patient’s response.

Excessive energy can increase inflammation and pigmentary complications, while insufficient energy may fail to adequately disrupt the dermal pigment.

Spot size can influence treatment depth and safety

Variable spot sizes allow the practitioner to adapt energy delivery to the lesion and the intended depth. Larger spots may support deeper, more uniform penetration, while smaller spots can be useful for precision in selected areas.

These adjustments should be made clinically rather than using identical settings for every patient or every macule.

Multiple sessions are often necessary

Dermal pigment is not always cleared after one treatment. Improvement generally depends on repeated treatment and the body’s gradual removal of fragmented pigment.

The number of sessions varies with pigment density, lesion depth, skin type, treatment parameters, and the patient’s tendency to develop post-inflammatory pigmentation.

Understanding the Trade-offs

Dual wavelengths do not guarantee complete clearance

Although combined treatment can improve clearance compared with a single wavelength, some lesions may persist or recur. Biological variation, uneven pigment depth, and incomplete response can limit the final result.

A good response should therefore be described as more likely or more comprehensive—not guaranteed.

Pigmentary changes remain possible

Q-switched Nd:YAG treatment can cause temporary redness, swelling, crusting, hypopigmentation, or post-inflammatory hyperpigmentation. These risks can be more clinically important in darker skin types.

Careful parameter selection, sun protection, and appropriate spacing between treatments are essential for risk management.

The 532 nm wavelength requires particular caution

Because 532 nm is more strongly absorbed by superficial melanin, it can produce more epidermal heating than 1064 nm. It may therefore carry a greater risk of superficial pigmentary alteration if used too aggressively, especially in patients with higher epidermal melanin content.

This is why 532 nm should be used selectively and not assumed to be universally safer or more effective than 1064 nm.

Treatment technique matters as much as device capability

A dual-wavelength device provides flexibility, but it does not automatically produce better outcomes. Diagnosis, patient selection, wavelength choice, fluence, endpoint assessment, and aftercare all influence safety and effectiveness.

ABNOM should also be distinguished from conditions such as nevus of Ota, melasma, post-inflammatory hyperpigmentation, and other melanocytic lesions before treatment.

Making the Right Choice for Your Goal

Dual-wavelength therapy is most useful when the clinical objective is to address ABNOM pigment distributed at different depths.

If your primary focus is maximal pigment clearance: Use a treatment strategy that combines appropriately selected 532 nm and 1064 nm parameters to cover superficial and deeper pigment components.
If your primary focus is safety in a darker skin type: Prioritize conservative settings, careful use of 532 nm, adequate treatment intervals, and rigorous sun protection to reduce pigmentary complications.
If your primary focus is treating deeper dermal macules: The 1064 nm wavelength is generally the principal component because of its greater penetration and lower epidermal melanin absorption.
If your primary focus is precision and individualized care: Adjust fluence, spot size, and wavelength according to lesion depth, skin type, and treatment response rather than applying a fixed protocol.

Understanding the depth of ABNOM pigment—and matching laser wavelength and pulse delivery to that depth—is the key to using dual-wavelength Q-switched Nd:YAG therapy effectively.

Summary Table:

Wavelength	Depth of Action	Key Role in ABNOM Treatment	Clinical Considerations
532 nm	Superficial (epidermal/dermal)	Targets shallow pigment components; useful for mixed-depth lesions.	Higher epidermal absorption; caution in darker skin types to avoid dyspigmentation.
1064 nm	Deep (dermal)	Mainly addresses dermal melanocytes; penetrates deeper with less epidermal absorption.	Principal for ABNOM; may be used with higher fluences for deeper clearance.

Key Advantages of Dual-Wavelength Therapy:

Comprehensive Depth Coverage: Targets both superficial and deep pigment, improving clearance rates.
Selective Pigment Disruption: Q-switched pulses fragment melanin with minimal collateral thermal damage.
Customizable Treatment: Allows adjustment of wavelengths, fluence, and spot size based on lesion depth and skin type.
Improved Efficacy: Combined therapy often yields higher complete-clearance rates than single-wavelength approaches.

Important Caveats:

Requires proper technique, parameter selection, and patient assessment.
Multiple sessions are typically needed for optimal results.
Risk of post-inflammatory hyperpigmentation exists; sun protection is essential.
Not all lesions respond fully; outcomes vary individually.

Ready to enhance your aesthetic practice with cutting-edge laser technology? At BELIS, we specialize in advanced medical aesthetic equipment for clinics and premium salons. Our portfolio includes the latest dual-wavelength Q-switched Nd:YAG lasers, along with other systems like Diode, Alexandrite, CO2, Erbium, Nd:YAG, Pico, IPL, and PDT devices, plus HIFU, Microneedle RF, body sculpting solutions, Hydrafacial, and more. Whether you're treating ABNOM or expanding your service offerings, we provide professional-grade tools with certified quality and reliable support. For distributors, we offer OEM/ODM services, attractive margins, and global certifications. Contact us today to discuss your needs and find the perfect equipment solution for your business!